{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:41:04Z","timestamp":1793032864335,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijpx.2026.100622","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T22:09:39Z","timestamp":1785103779000},"page":"100622","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Liposomal Gel for enhancing topical efficacy of timolol maleate against proliferating superficial infantile hemangiomas"],"prefix":"10.1016","volume":"12","author":[{"given":"Xiaoxing","family":"Hang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiwei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuenong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2026.100622_bb0005","doi-asserted-by":"crossref","first-page":"9783","DOI":"10.2147\/IJN.S278688","article-title":"Bilosomes as promising nanovesicular carriers for improved transdermal delivery: construction, in vitro optimization, ex vivo permeation and in vivo evaluation","volume":"15","author":"Ahmed","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpx.2026.100622_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2024.113907","article-title":"Multicenter study of long-term outcomes and quality of life in PHACE syndrome after age 10","volume":"267","author":"Braun","year":"2024","journal-title":"J. Pediatr."},{"issue":"7","key":"10.1016\/j.ijpx.2026.100622_bb0025","first-page":"493","article-title":"Chinese expert consensus on the use of beta-blockers for the treatment of infantile hemangiomas","volume":"53","author":"Chinese Society of Dermatology, Subcommittee of Dermatovenerology","year":"2020","journal-title":"Chin. J. Dermatol."},{"issue":"5","key":"10.1016\/j.ijpx.2026.100622_bb0030","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jpeds.2008.05.043","article-title":"Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants","volume":"153","author":"Drolet","year":"2008","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ijpx.2026.100622_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/1477-3155-10-9","article-title":"Sendai virus-based liposomes enable targeted cytosolic delivery of nanoparticles in brain tumor-derived cells","volume":"10","author":"Dudu","year":"2012","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijpx.2026.100622_bb0040","article-title":"Repurposing celecoxib for colorectal cancer targeting via pH-triggered ultra-elastic nanovesicles: pronounced efficacy through up-regulation of Wnt\/\u03b2-catenin pathway in DMH-induced tumorigenesis","volume":"7","author":"El Menshawe","year":"2024","journal-title":"Int. J. Pharm. X"},{"issue":"5","key":"10.1016\/j.ijpx.2026.100622_bb0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200342050-00002","article-title":"Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies","volume":"42","author":"Gabizon","year":"2003","journal-title":"Clin. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.ijpx.2026.100622_bb0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archophthalmol.2009.370","article-title":"Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution","volume":"128","author":"Guo","year":"2010","journal-title":"Arch. Ophthalmol."},{"issue":"8","key":"10.1016\/j.ijpx.2026.100622_bb0065","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1111\/jocd.15000","article-title":"Studies on stratum corneum metabolism: function, molecular mechanism and influencing factors","volume":"21","author":"Jiao","year":"2022","journal-title":"J. Cosmet. Dermatol."},{"issue":"1","key":"10.1016\/j.ijpx.2026.100622_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jat.3004","article-title":"Animal models for percutaneous absorption","volume":"35","author":"Jung","year":"2015","journal-title":"J. Appl. Toxicol."},{"issue":"10","key":"10.1016\/j.ijpx.2026.100622_bb0075","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2340\/00015555-2681","article-title":"The role of topical timolol in the treatment of infantile hemangiomas: a systematic review and meta-analysis","volume":"97","author":"Khan","year":"2017","journal-title":"Acta Derm. Venereol."},{"issue":"1","key":"10.1016\/j.ijpx.2026.100622_bb0085","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-3475","article-title":"Clinical practice guideline for the management of infantile hemangiomas","volume":"143","author":"Krowchuk","year":"2019","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.ijpx.2026.100622_bb0090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/bjd.13379","article-title":"Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas","volume":"172","author":"Langley","year":"2015","journal-title":"Br. J. Dermatol."},{"issue":"24","key":"10.1016\/j.ijpx.2026.100622_bb0095","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"10089","key":"10.1016\/j.ijpx.2026.100622_bb0100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0140-6736(16)00645-0","article-title":"Infantile haemangioma","volume":"390","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ijpx.2026.100622_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat. Rev. Mater."},{"issue":"24","key":"10.1016\/j.ijpx.2026.100622_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415585","article-title":"The VEGF\/VEGFR axis revisited: implications for cancer therapy","volume":"23","author":"Mabeta","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijpx.2026.100622_bb0125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.abd.2021.05.009","article-title":"Infantile hemangiomas: risk factors for complications, recurrence and unaesthetic sequelae","volume":"97","author":"Mariani","year":"2022","journal-title":"An. Bras. Dermatol."},{"issue":"5","key":"10.1016\/j.ijpx.2026.100622_bb0130","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jare.2016.07.003","article-title":"Improved bioavailability of timolol maleate via transdermal transfersomal gel: statistical optimization, characterization, and pharmacokinetic assessment","volume":"7","author":"Morsi","year":"2016","journal-title":"J. Adv. Res."},{"issue":"3","key":"10.1016\/j.ijpx.2026.100622_bb0140","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/archophthalmol.2011.24","article-title":"Topical timolol for periocular hemangioma: report of further study","volume":"129","author":"Ni","year":"2011","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.ijpx.2026.100622_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0046-8177(00)80192-6","article-title":"GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas","volume":"31","author":"North","year":"2000","journal-title":"Hum. Pathol."},{"issue":"5","key":"10.1016\/j.ijpx.2026.100622_bb0150","first-page":"559","article-title":"A unique microvascular phenotype shared by juvenile hemangiomas and human placenta","volume":"137","author":"North","year":"2001","journal-title":"Arch. Dermatol."},{"issue":"4","key":"10.1016\/j.ijpx.2026.100622_bb0155","article-title":"Interventions for infantile haemangiomas of the skin","volume":"4","author":"Novoa","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijpx.2026.100622_bb0165","article-title":"Augmented glycerosomes as a promising approach against fungal ear infection: optimization and microbiological, ex vivo and in vivo assessments","volume":"8","author":"Sadek Ahmed","year":"2024","journal-title":"Int. J. Pharm. X"},{"issue":"1","key":"10.1016\/j.ijpx.2026.100622_bb0170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/pde.15132","article-title":"Multicenter retrospective review of pulsed dye laser in nonulcerated infantile hemangioma","volume":"40","author":"Shah","year":"2023","journal-title":"Pediatr. Dermatol."},{"issue":"1","key":"10.1016\/j.ijpx.2026.100622_bb0175","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijpharm.2011.03.051","article-title":"Higuchi equation: derivation, applications and limitations","volume":"418","author":"Siepmann","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ijpx.2026.100622_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/gels9050352","article-title":"Gel formulations for topical treatment of skin cancer: a review","volume":"9","author":"Slavkova","year":"2023","journal-title":"Gels"},{"key":"10.1016\/j.ijpx.2026.100622_bb0190","article-title":"Skin can modulate the pH of topical creams and gels","volume":"26","author":"Soujanya","year":"2025","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.ijpx.2026.100622_bb0195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","article-title":"Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action","volume":"163","author":"Storch","year":"2010","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.ijpx.2026.100622_bb0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.11622\/smedj.2020008","article-title":"Oral propranolol for the treatment of infantile haemangiomas in Singapore","volume":"62","author":"Tan","year":"2021","journal-title":"Singapore Med. J."},{"issue":"10","key":"10.1016\/j.ijpx.2026.100622_bb0205","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5070\/D37B37M8DJ","article-title":"Abortive segmental perineal hemangioma","volume":"17","author":"Tlougan","year":"2011","journal-title":"Dermatol. Online J."},{"issue":"9","key":"10.1016\/j.ijpx.2026.100622_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801261","article-title":"Propranolol-loaded mesoporous silica nanoparticles for treatment of infantile hemangiomas","volume":"8","author":"Wu","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijpx.2026.100622_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1064048","article-title":"Management of infantile hemangiomas: recent advances","volume":"12","author":"Xu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijpx.2026.100622_bb0230","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jconrel.2022.12.028","article-title":"Applications and challenges of ultra-small particle size nanoparticles in tumor therapy","volume":"353","author":"Xu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100622_bb0235","article-title":"Engineered lecithin-based proniosomes for enhanced trans-tympanic permeation: in vitro, microbiological, ex vivo and in vivo evaluation","volume":"96","author":"Younes","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100622_bb0240","article-title":"Radiolabeling of statistically optimized nanosized atorvastatin suspension for liver targeting and extensive imaging of hepatocellular carcinoma","volume":"80","author":"Yousry","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100622_bib246","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s41379-020-00702-9","article-title":"Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes","volume":"34","author":"Yugawa","year":"2021","journal-title":"Mod. Patol."},{"issue":"1","key":"10.1016\/j.ijpx.2026.100622_bb0245","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13578-022-00856-w","article-title":"New insights into fibrosis from the ECM degradation perspective: the macrophage-MMP-ECM interaction","volume":"12","author":"Zhao","year":"2022","journal-title":"Cell Biosci."}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001428?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001428?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:07:15Z","timestamp":1793030835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156726001428"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":38,"alternative-id":["S2590156726001428"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100622","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liposomal Gel for enhancing topical efficacy of timolol maleate against proliferating superficial infantile hemangiomas","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100622","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100622"}}